Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 1994Thrombosis and Haemostasis

Low Molecular Weight Heparin Therapy: Is Monitoring Needed?

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does laboratory monitoring of anti-Xa activity improve safety and efficacy in patients receiving LMWH for DVT prevention or treatment?

Population

Patients receiving low molecular weight heparin for the prevention or treatment of deep vein thrombosis

Comparison

Laboratory monitoring of anti-Xa activity vs No monitoring

Design

Review

Authors

BBB BoneuCentre National de la Recherche Scientifique

Discussion

Loading...

Member takes

Implication

Supports omitting routine anti-Xa monitoring for LMWH DVT prophylaxis; leaves open its role in treatment and requires prospective trials.

Key Points

  • To assess the necessity of monitoring low molecular weight heparin (LMWH) therapy in treating deep vein thrombosis (DVT).
  • Analysis of recent meta-analyses comparing LMWH and unfractionated heparin (UH)
  • Evaluation of clinical trials regarding the effectiveness and risk associated with varying LMWH doses
  • Review of the available testing methods for monitoring anti Xa activity in plasma.
  • LMWH is more effective than UH in preventing and treating DVT, with lower bleeding risks noted.
  • Clinical trials show that monitoring anti Xa activity in most cases is not required, especially during prevention.
  • Initial checks of anti Xa activity may be useful, but regular monitoring is unnecessary as many patients fall within therapeutic range.

Structured PICO

Does laboratory monitoring of anti-Xa activity improve safety and efficacy in patients receiving LMWH for DVT prevention or treatment?

P
Population
Patients receiving low molecular weight heparin (LMWH) for the prevention or treatment of deep vein thrombosis (DVT)
I
Intervention
Laboratory monitoring of anti-Xa activity
C
Comparator
No monitoring
O
Outcome
Efficacy and safety (haemorrhagic risk)

Routine laboratory monitoring of LMWH is not required for DVT prevention, though its role in DVT treatment remains uncertain.

Cite This Study

B Boneu (1994) studied this question.

synapsesocial.com/papers/6a7013d575498292b70972bbhttps://doi.org/10.1055/s-0038-1648866
View Full Paper
Ask AI
Bookmark
Share